FURADANTIN (nitrofurantoin) by Aurobindo Pharma is clinical pharmacology each nitrofurantoin capsule (monohydrate/macrocrystals) contains two forms of nitrofurantoin. First approved in 1953.
Drug data last refreshed 5h ago · AI intelligence enriched 1mo ago
Nitrofurantoin (FURADANTIN) is an oral antibiotic indicated for urinary tract infections, utilizing a dual-release formulation combining 75% monohydrate (gel-matrix) and 25% macrocrystals for optimized urinary drug delivery. The drug works by inhibiting bacterial enzymes essential for cell wall synthesis, achieving high urinary concentrations while maintaining low systemic plasma levels. It has been the standard-of-care agent for uncomplicated UTIs since its FDA approval in 1953.
As a mature, off-patent product with LOE approaching, the brand team is likely focused on generic defense and cost-containment strategies rather than expansion.
CLINICAL PHARMACOLOGY Each nitrofurantoin capsule (monohydrate/macrocrystals) contains two forms of nitrofurantoin. Twenty-five percent is macrocrystalline nitrofurantoin, which has slower dissolution and absorption than nitrofurantoin monohydrate. The remaining 75% is nitrofurantoin monohydrate…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study
Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI)
Oral Omadacycline vs. Oral Nitrofurantoin for the Treatment of Cystitis
Food Study of Nitrofurantoin Macrocrystals 100 mg Capsules and Macrodantin® 100 mg
Food Study of Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg
Worked on FURADANTIN at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on FURADANTIN represents a late-stage career opportunity focused on defensive commercial strategy, cost optimization, and market-access maintenance rather than innovation or launch excitement. This role is ideal for professionals with expertise in generic competition management, mature-market reimbursement, and portfolio wind-down strategies.